Literature DB >> 22054232

Sedative load among community-dwelling people aged 75 years and older: a population-based study.

Heidi T Taipale1, J Simon Bell, Maija Uusi-Kokko, Eija Lönnroos, Raimo Sulkava, Sirpa Hartikainen.   

Abstract

BACKGROUND: Drugs with sedative properties are among the most widely used drugs in community-dwelling older people. Use of sedative drugs has been associated with falls and fractures, cognitive and memory impairment and impaired physical function among older people. The sedative load model has been developed to quantify the cumulative effect of taking multiple drugs with sedative properties.
OBJECTIVE: The objective of the study was to investigate factors associated with sedative load among community-dwelling older people, using data collected as part of the Finnish Geriatric Multidisciplinary Strategy for the Good Care of the Elderly (GeMS) study.
METHODS: The GeMS study was a randomized, comparative study that evaluated a model for geriatric assessment, care and rehabilitation using a study sample of 1000 persons aged≥75 years who were living in Kuopio, Finland. Of these, 700 people consented to participate and were community-dwelling. Demographic, diagnostic and drug use data (both regular and when-required drugs) were elicited during nurse interviews. For the current analysis, sedative load was computed using a previously published model, in which drugs taken on a regular and when-required basis were classified into one of four groups according to their sedative potential. Group 1 included primary sedatives (sedative rating 2) and group 2 included drugs with sedation as a prominent side effect (sedative rating 1). Each participant's sedative load was calculated by summing the sedative ratings of group 1 and 2 drugs. Logistic regression models were used to investigate factors associated with sedative load.
RESULTS: Twenty-nine percent of participants (n=205) had a sedative load of ≥1 (i.e. used one or more drugs with sedative properties), and 22% (n=158) had a sedative load of ≥2 (i.e. used either one primary sedative or two drugs with sedation as a prominent adverse effect or preparations with a sedating component) when considering regularly used drugs. A sedative load of ≥2 that related to regularly used drugs was associated with female sex (odds ratio [OR] 1.65; 95% CI 1.02, 2.67), poor self-perceived health (OR 2.06; 95% CI 1.25, 3.38), impaired instrumental activities of daily living [IADL] (OR 1.89; 95% CI 1.18, 3.01) and often feeling lonely (OR 4.72; 95% CI 2.15, 10.40). The same factors remained significantly associated with a sedative load of ≥2 after drugs used on a when-required basis were included in the analyses.
CONCLUSIONS: The advantages of the sedative load model were that it included drugs with sedative properties prescribed for somatic diseases, described cumulative exposure to drugs that exert sedative effects through multiple mechanisms in the CNS, and incorporated a sedative rating for each drug. In an older population, female sex, impaired IADL, poor self-perceived health, and loneliness were associated with higher sedative load. Clinicians should remain cognizant of these factors when reviewing drug regimens and targeting interventions to optimize sedative use.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22054232     DOI: 10.2165/11597800-000000000-00000

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  44 in total

Review 1.  Understanding antipsychotic "atypicality": a clinical and pharmacological moving target.

Authors:  Gary Remington
Journal:  J Psychiatry Neurosci       Date:  2003-07       Impact factor: 6.186

2.  Sedative load and mortality among residents of long-term care facilities: a prospective cohort study.

Authors:  Heidi T Taipale; J Simon Bell; Helena Soini; Kaisu H Pitkälä
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

3.  Sedative load among long-term care facility residents with and without dementia: a cross-sectional study.

Authors:  J Simon Bell; Heidi T Taipale; Helena Soini; Kaisu H Pitkälä
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

4.  Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use.

Authors:  A Fourrier; L Letenneur; J F Dartigues; N Moore; B Bégaud
Journal:  Eur J Clin Pharmacol       Date:  2001-08       Impact factor: 2.953

5.  Dementia management programme in a community setting and the use of psychotropic drugs in the elderly population.

Authors:  Erik Jedenius; Kristina Johnell; Johan Fastbom; Jan Strömqvist; Bengt Winblad; Niels Andreasen
Journal:  Scand J Prim Health Care       Date:  2011-07-11       Impact factor: 2.581

6.  Long-term continuous use of benzodiazepines by older adults in Quebec: prevalence, incidence and risk factors.

Authors:  M Egan; Y Moride; C Wolfson; J Monette
Journal:  J Am Geriatr Soc       Date:  2000-07       Impact factor: 5.562

7.  Psychotropics use in the Spanish elderly: predictors and evolution between years 1993 and 2003.

Authors:  P Carrasco-Garrido; R Jiménez-García; P Astasio-Arbiza; P Ortega-Molina; A Gil de Miguel
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-04       Impact factor: 2.890

8.  Risk factors for injurious falls leading to hospitalization or death in a cohort of 19,500 adults.

Authors:  A Malmivaara; M Heliövaara; P Knekt; A Reunanen; A Aromaa
Journal:  Am J Epidemiol       Date:  1993-09-15       Impact factor: 4.897

Review 9.  Clinical pharmacology in the geriatric patient.

Authors:  Sarah N Hilmer; Andrew J McLachlan; David G Le Couteur
Journal:  Fundam Clin Pharmacol       Date:  2007-06       Impact factor: 2.748

10.  Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition study.

Authors:  Joseph T Hanlon; Robert M Boudreau; Yazan F Roumani; Anne B Newman; Christine M Ruby; Rollin M Wright; Sarah N Hilmer; Ronald I Shorr; Douglas C Bauer; Eleanor M Simonsick; Stephanie A Studenski
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-02-04       Impact factor: 6.053

View more
  3 in total

1.  Loneliness and Illicit Opioid Use Among Methadone Maintenance Treatment Patients.

Authors:  Courtney A Polenick; Brandi Parker Cotton; William C Bryson; Kira S Birditt
Journal:  Subst Use Misuse       Date:  2019-06-24       Impact factor: 2.164

2.  Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study.

Authors:  Anna-Maija Tolppanen; Heidi Taipale; Antti Tanskanen; Jari Tiihonen; Sirpa Hartikainen
Journal:  BMC Geriatr       Date:  2016-12-01       Impact factor: 3.921

3.  Polypharmacy among older adults with dementia compared with those without dementia in the United States.

Authors:  Matthew E Growdon; Siqi Gan; Kristine Yaffe; Michael A Steinman
Journal:  J Am Geriatr Soc       Date:  2021-06-08       Impact factor: 7.538

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.